York-based Aptamer Group plc said it has formed a partnership with Microsaic Systems to develop a panel of Optimer binders that can detect pathogens in water. 

Aptamer said earlier work with its COVID-19 Optimer binders and the Microtox water testing system, recently purchased by Microsaic, showed successful integration and function of the Optimer.

The company said it will develop a number of new Optimer binders to common waterborne pathogens, such as E.coli, Cholera, Cryptosporidium, Legionella and Norovirus. Following development, the binders will be available for integration into the water pathogen detectors for the rapid and sensitive detection of multiple pathogens of serious concern to public health. 

“Successful trials have previously taken place using the Optimer-enabled pathogen detectors for COVID-19 within the UK wastewater system,” Aptamer said. “Following the Microtox acquisition, Microsaic intends to further develop the device to commerciality using a panel of Optimer binders that specifically detect several major waterborne pathogens.”

Aptamer said: “This continuous water testing solution will allow the detection of pathogens in real-time, without delays associated with sending samples for laboratory-based testing, and has shown to be simply integrated with nationwide water systems for early detection of potential infections.”